title: Putting health metrics into practice: using the disability-adjusted life year for strategic decision making.
abstract: BACKGROUND
  Implementing organizations are pressured to be accountable for performance. Many health impact metrics present limitations for priority setting; they do not permit comparisons across different interventions or health areas. In response, Population Services International (PSI) adopted the disability-adjusted life year (DALY) averted as its bottom-line performance metric. While international standards exist for calculating DALYs to determine burden of disease (BOD), PSI's use of DALYs averted is novel. It uses DALYs averted to assess and compare the health impact of its country programs, and to understand the effectiveness of a portfolio of interventions. This paper describes how the adoption of DALYs averted influenced organizational strategy and presents the advantages and constraints of using the metric.
  
  
  METHODS
  Health impact data from 2001-2011 were analyzed by program area and geographic region to measure PSI's performance against its goal of doubling health impact between 2007-2011. Analyzing 10 years of data permitted comparison with previous years' performance. A case study of PSI's Asia and Eastern European (A/EE) region, and PSI/Laos, is presented to illustrate how the adoption of DALYs averted affected strategic decision making.
  
  
  RESULTS
  Between 2007-2011, PSI's programs doubled the total number of DALYs averted from 2002-2006. Most DALYs averted were within malaria, followed by HIV/AIDS and family planning (FP). The performance of PSI's A/EE region relative to other regions declined with the switch to DALYs averted. As a result, the region made a strategic shift to align its work with countries' BOD. In PSI/Laos, this redirection led to better-targeted programs and an approximate 50% gain in DALYs averted from 2009-2011.
  
  
  CONCLUSIONS
  PSI's adoption of DALYs averted shifted the organization's strategic direction away from product sales and toward BOD. Now, many strategic decisions are based on "BOD-relevance," the share of the BOD that interventions can potentially address. This switch resulted in more targeted strategies and greater program diversification. Challenges remain in convincing donors to support interventions in disease areas that are relevant to a country's BOD, and in developing modeling methodologies. The global health community will benefit from the use of standard health impact metrics to improve strategic decision making and more effectively respond to the changing global burden of disease.
authors.affiliation: Population Services International, 1120 19th Street NW, Suite 600, Washington, DC 20036, USA. klongfield@psi.org
authors.forename: Kim
authors.initials: K
authors.lastname: Longfield
authors.forename: Brian
authors.initials: B
authors.lastname: Smith
authors.forename: Rob
authors.initials: R
authors.lastname: Gray
authors.forename: Lek
authors.initials: L
authors.lastname: Ngamkitpaiboon
authors.forename: Nadja
authors.initials: N
authors.lastname: Vielot
mesh_terms: D003659:Decision Making, Organizational; D006233:Persons with Disabilities / Q000706:statistics & numerical data*; D006801:Humans; D007390:International Agencies / Q000458:organization & administration*; D015397:Program Evaluation / Q000379:methods*; D019057:Quality-Adjusted Life Years
references.citation: Bull World Health Organ. 1994;72(3):495-509
references.pmid: 8062404
references.citation: Environ Manage. 2005 May;35(5):667-76
references.pmid: 15920669
references.citation: PLoS One. 2012;7(2):e31316
references.pmid: 22347462
references.citation: Popul Health Metr. 2009 Jun 15;7:9
references.pmid: 19527516
references.citation: BMC Public Health. 2011 Apr 13;11 Suppl 3:I1
references.pmid: 21501425
references.citation: World J Surg. 2006 Apr;30(4):505-11
references.pmid: 16528459
references.citation: J Clin Virol. 2011 Nov;52(3):215-21
references.pmid: 21880543
references.citation: Lancet. 2008 Apr 5;371(9619):1191-9
references.pmid: 18395581
references.citation: Econ Hum Biol. 2011 Jan;9(1):14-22
references.pmid: 20951103
references.citation: BMJ. 2005 Dec 10;331(7529):1364
references.pmid: 16282379
references.citation: Int J Epidemiol. 2010 Apr;39 Suppl 1:i21-31
references.pmid: 20348122
references.citation: Int J Gynaecol Obstet. 2011 Nov;115 Suppl 1:S20-5
references.pmid: 22099435
references.citation: J Acquir Immune Defic Syndr. 2012 May 1;60(1):e8-e14
references.pmid: 22240461
references.citation: Popul Health Metr. 2011 Jan 10;9(1):1
references.pmid: 21219615
references.citation: J Vector Borne Dis. 2009 Mar;46(1):26-35
references.pmid: 19326705
references.citation: PLoS One. 2007 Aug 15;2(8):e750
references.pmid: 17710149
references.citation: PLoS Negl Trop Dis. 2007 Nov 07;1(2):e114
references.pmid: 18060077
references.citation: Health Econ. 2000 Jan;9(1):69-82
references.pmid: 10694761
references.citation: JAMA. 2001 Feb 7;285(5):535-9
references.pmid: 11176854
references.citation: Bull World Health Organ. 2004 Sep;82(9):643-51
references.pmid: 15628201
references.citation: PLoS Negl Trop Dis. 2009 Oct 27;3(10):e460
references.pmid: 19859534
references.citation: PLoS Negl Trop Dis. 2008;2(12):e333
references.pmid: 19104653
references.citation: BMC Public Health. 2010 May 14;10:253
references.pmid: 20470426
references.citation: Int J Epidemiol. 2010 Apr;39 Suppl 1:i7-10
references.pmid: 20348129
references.citation: BMC Public Health. 2005 Dec 12;5:130
references.pmid: 16343345
references.citation: Pharmacoeconomics. 2001;19(9):937-46
references.pmid: 11700780
references.citation: Bull World Health Organ. 1994;72(3):481-94
references.pmid: 8062403
references.citation: J Epidemiol Community Health. 2011 Sep;65(9):751-6
references.pmid: 21097808
references.citation: Eval Rev. 2000 Feb;24(1):3-46
references.pmid: 10747769
references.citation: BMJ. 2005 Dec 17;331(7530):1431-7
references.pmid: 16282380
references.citation: BMC Public Health. 2013;13 Suppl 2:S3
references.pmid: 23902668
references.citation: Rev Panam Salud Publica. 2011 Nov;30(5):453-60
references.pmid: 22262272